Tema Oncology ETFCANCETF
13F holders, Q3 2024 (September 30)5holders +1
1new positions
0sold out
$28.41avg. 13F price*
At the end of Q3 2024, 5 institutions reported holding Tema Oncology ETF (CANC) in their 13F filings, up 1 from Q2 2024. 1 opened new positions and 0 sold out. The largest holders were Thrivent Financial for Lutherans ($11.4M), Jane Street Group, LLC ($1.3M) and Harbour Investments, Inc. ($9K).
- Company
- Tema Oncology ETF
- Filed as
- TEMA ETF TRUST (Q3 2024)
- CUSIP
- 87975E701
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $3K |
| Exits | 0 | $0 |
All 13F filers, Q2 2024 → Q3 2024: 80,254 shares bought and 98,880 shares sold, net −18,626 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| Thrivent Financial for Lutherans | 0.02% | Add +25.1% | 399,509 | $11.4M |
| Jane Street Group, LLC | 0.00% | Reduce -69.0% | 44,311 | $1.3M |
| Harbour Investments, Inc. | 0.00% | No change | 316 | $9K |
| Osaic Holdings, Inc. | 0.00% | No change | 200 | $6K |
| Royal Bank of Canada | 0.00% | New | 121 | $3K |
"% of holder's portfolio" is CANC's weight in each manager's 13F, not the share of Tema Oncology ETF the manager owns.